Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

This study has been terminated.

(Difficulties in completing the required sample size)

Sponsor:

Collaborator:

AstraZeneca

Information provided by (Responsible Party):

Fundación Cardiovascular de Colombia

ClinicalTrials.gov Identifier:

NCT00319202

First received: April 26, 2006

Last updated: November 2, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2012
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)